Adagio Medical Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Adagio Medical Holdings, Inc. (ADGM) on October 23, 2025. The filing announces the scheduling of the Company's 2025 Annual Meeting of Stockholders. The Company is an emerging growth company incorporated in Delaware.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a corporate governance notification and does not contain financial performance data.
Material Changes
The primary material event is the establishment of the 2025 Annual Meeting date. The Company notes that it did not hold a 2024 Annual Meeting of Stockholders, necessitating this filing to inform stockholders of the upcoming 2025 meeting schedule and proposal deadlines.
Guidance, Outlook, and Management Commentary
- Meeting Date: The 2025 Annual Meeting is scheduled for December 15, 2025. The specific time and location will be disclosed in the definitive proxy statement.
- Record Date: The record date for determining stockholders entitled to vote is the close of business on October 31, 2025.
- Proposal Deadlines: Stockholders must submit proposals for inclusion in proxy materials (Rule 14a-8) and director nominations (Bylaws and Rule 14a-19) no later than November 3, 2025.
- Submission Address: Proposals and notices must be delivered to the Company Secretary at 26051 Merit Circle, Suite 102, Laguna Hills, CA 92653.
Key Facts for Investor Verification
- Verify the definitive proxy statement for the exact time and location of the December 15, 2025, Annual Meeting.
- Confirm the November 3, 2025, deadline for submitting stockholder proposals and director nominations.
- Note the October 31, 2025, record date for voting eligibility.
- Review the Company's Bylaws for specific information requirements regarding stockholder notices.